Evidence map›Paper›PMID 30630163›Full record

Observational studyUrologia internationalis2019

Clinical Outcomes of ABO-Incompatible Kidney Transplantation in Patients with End-Stage Kidney Disease due to Diabetes Nephropathy.

Junji Uchida, Akihiro Kosoku, Kazuya Kabei, Shunji Nishide, Hisao Shimada, Tomoaki Iwai, Nobuyuki Kuwabara, Toshihide Naganuma, Keiko Maeda, Norihiko Kumada and 2 more

Open access · hybridAbstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Urologia internationalis, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Latest insights on ABO-incompatible living-donor renal transplantation.International journal of urology : official journal of the Japanese Urological Association · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Junji UchidaDepartment of Urology, Osaka City University Graduate School of Medicine, Osaka, Japan, m9492120@msic.med.osaka-cu.ac.jp.
Akihiro KosokuDepartment of Urology, Osaka City University Graduate School of Medicine, Osaka, Japan.
Kazuya KabeiDepartment of Urology, Osaka City University Graduate School of Medicine, Osaka, Japan.
Shunji NishideDepartment of Urology, Osaka City University Graduate School of Medicine, Osaka, Japan.
Hisao ShimadaDepartment of Urology, Osaka City University Graduate School of Medicine, Osaka, Japan.
Tomoaki IwaiDepartment of Urology, Osaka City University Graduate School of Medicine, Osaka, Japan.
Nobuyuki KuwabaraDepartment of Urology, Osaka City University Graduate School of Medicine, Osaka, Japan.
Toshihide NaganumaDepartment of Urology, Osaka City University Graduate School of Medicine, Osaka, Japan.
Keiko MaedaDepartment of Nursing, Osaka City University Hospital, Osaka, Japan.
Norihiko KumadaDepartment of Urology, Suita Municipal Hospital, Suita, Japan.
Yoshiaki TakemotoDepartment of Urology, Osaka City University Graduate School of Medicine, Osaka, Japan.
Tatsuya NakataniDepartment of Urology, Osaka City University Graduate School of Medicine, Osaka, Japan.
Osaka City University · JPOsaka City University Hospital · JPSuita Municipal Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiabetes nephropathy is one of the most common causes of end-stage kidney disease (ESKD) worldwide. The data are clear that kidney transplantation is superior to remaining on dialysis for patients with diabetes. However, there have been no reports on ABO-incompatible kidney transplantation in patients with ESKD due to diabetes nephropathy. PATIENTS AND

methodsWe conducted a retrospective, observational study to investigate the clinical outcomes of ABO-incompatible kidney transplantation for patients with pre-existing diabetes nephropathy at our institution from April 2011 to October 2017. A total of 14 recipients were enrolled in this study.

resultsAll 14 patients underwent successful kidney transplantation. Both overall patient and graft survival rates were 100, 89.9, and 89.9% at 1, 3, and 5 years, respectively. One patient died 20 months after transplantation with a functioning graft due to pancreas cancer. Two of the 14 patients (14.3%) developed biopsy-proven acute cellular rejection during the follow-up period. The median observation period was 32.0 months (range 5-83 months).

conclusionABO-incompatible kidney transplantation may be an acceptable renal replacement therapy for ESKD patients with diabetes.

Indexed as

ABO Blood-Group SystemBlood Group IncompatibilityKidney TransplantationAdultAgedBiopsyDiabetic NephropathiesFemaleGraft RejectionGraft SurvivalHumansImmunoglobulin GImmunoglobulin MImmunosuppression TherapyKidney Failure, ChronicMaleABO Blood-Group SystemImmunoglobulin GImmunoglobulin MABO-incompatibleDiabetes mellitusKidney transplantation

Identifiers

PMID30630163
PMCPMC6518853
OpenAlexW2909772430

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.